Onset of Action, Maintenance and Persistence of Response to Dupilumab in chronic Rhinosinusitis with Nasal Polyps

被引：0
|
作者：
Bachert, C. [1 ,2 ,3 ]
Khan, A. H. [4 ]
Fokkens, W. J. [5 ]
Hopkins, C. [6 ]
Gevaert, P. [1 ]
Han, J. K. [7 ]
Hellings, P. [8 ]
Lee, S. E. [9 ]
Msihid, J. [4 ]
Nash, S. [10 ]
Siddiqui, S. [10 ]
Jacob-Nara, J. A. [11 ]
Deniz, Y. [10 ]
Rowe, P. J. [11 ]
机构：
[1] Univ Ghent, Ghent, Belgium
[2] Karolinska Inst, Stockholm, Sweden
[3] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
[4] Sanofi, Chilly Mazarin, France
[5] Univ Amsterdam, Med Ctr, Locat AMC, Amsterdam, Netherlands
[6] Kings Coll London, London, England
[7] Eastern Virginia Med Sch, Norfolk, VA 23501 USA
[8] Univ Hosp Leuven, Leuven, Belgium
[9] Harvard Med Sch, Brigham & Womens Hosp, Div Otolaryngol Head & Neck Surg, Boston, MA 02115 USA
[10] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[11] Sanofi, Bridgewater, NJ USA
来源：
ALLERGOLOGIE | 2022年 / 45卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P4.06
引用
收藏
页码：612 / 612
页数：1
相关论文
共 50 条
  • [1] Onset, Maintenance, and Durability of Response with Dupilumab in Chronic Rhinosinusitis with Nasal Polyps
    Bachert, C.
    Khan, A.
    Fokkens, W.
    Hopkins, C.
    Gevaert, P.
    Han, J.
    Hellings, P.
    Lee, S.
    Msihid, J.
    Nash, S.
    Siddiqui, S.
    Jacob-Nara, J.
    Deniz, Y.
    Rowe, P.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [2] Dupilumab: A Review in Chronic Rhinosinusitis with Nasal Polyps
    Sheridan M. Hoy
    Drugs, 2020, 80 : 711 - 717
  • [3] Dupilumab: A Review in Chronic Rhinosinusitis with Nasal Polyps
    Hoy, Sheridan M.
    DRUGS, 2020, 80 (07) : 711 - 717
  • [4] Impact of Overweight on Response to Dupilumab Treatment in Chronic Rhinosinusitis with Nasal Polyps
    Habenbacher, Michael
    Moser, Ulrich
    Abaira, Ahmed
    Tomazic, Peter Valentin
    Kiss, Peter
    Holzmeister, Clemens
    Pock, Jakob
    Walla, Katharina
    Lang, Angelika
    Andrianakis, Alexandros
    NUTRIENTS, 2024, 16 (17)
  • [5] Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps
    Mullol, Joaquim
    Bachert, Claus
    Amin, Nikhil
    Desrosiers, Martin
    Hellings, Peter W.
    Han, Joseph K.
    Jankowski, Roger
    Vodicka, Jan
    Gevaert, Philippe
    Daizadeh, Nadia
    Khan, Asif H.
    Kamat, Siddhesh
    Patel, Naimish
    Graham, Neil M. H.
    Ruddy, Marcella
    Staudinger, Heribert
    Mannent, Leda P.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (04): : 1086 - +
  • [6] Dupilumab improves sleep quality in chronic rhinosinusitis with nasal polyps
    Riva, Giuseppe
    Garetto, Marco
    Borgione, Mario
    Piazza, Federica
    Prizio, Carmine
    Dellea, Davide
    Albera, Andrea
    Canale, Andrea
    Pecorari, Giancarlo
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2024, 45 (04)
  • [7] Trends in Dupilumab Utilization for the Treatment of Chronic Rhinosinusitis With Nasal Polyps
    Xiao, Daniel
    Talmadge, Jason
    Citardi, Martin J.
    Yao, William C.
    Luong, Amber U.
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2024,
  • [8] Screening olfaction under dupilumab in chronic rhinosinusitis with nasal polyps
    Mauthe, Tina
    Meerwein, Christian M.
    Ryser, Fabio S.
    Bruehlmann, Catrin
    Yalamanoglu, Ayla
    Steiner, Urs C.
    Soyka, Michael B.
    RHINOLOGY, 2024, 62 (04) : 496 - 505
  • [9] Dupilumab in pediatric severe chronic rhinosinusitis with nasal polyps and asthma
    Amaral, L.
    Pereira, A. M.
    Braganca, M.
    Placido, J. L.
    EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES, 2024, 141 (01) : 55 - 56
  • [10] Chronic rhinosinusitis with nasal polyps Extension of the Dupilumab therapy intervals
    Appel, H.
    Hahn, J.
    ALLERGOLOGIE, 2023, 46 (08) : 548 - 548
12345